In Treatment of Bacterial infections Veecef CV 200mg/125mg Tablet helps treat infections that are caused by bacteria. It contains two medicines, Cefixime, and Clavulanic acid. Cefixime stops the growth of infection-causing bacteria. Clavulanic Acid enhances the activity of Cefixime against the bacteria as well as reduces resistance of the bacteria to the antibiotic. This medicine usually makes you feel better within a few days, but you should continue taking it as prescribed even when you feel better to make sure that all the infectious bacteria are killed and do not become resistant.
Caution is advised when consuming alcohol with Veecef CV 200mg/125mg Tablet. Please consult your doctor.
Veecef CV 200mg/125mg Tablet is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Veecef CV 200mg/125mg Tablet is safe to use during breastfeeding. Human studies suggest that the drug does not pass into the breastmilk in a significant amount and is not harmful to the baby.
Veecef CV 200mg/125mg Tablet may cause side effects which could affect your ability to drive. Veecef CV 200mg/125mg Tablet may cause side effects such as allergic reactions, dizziness or fits that may make you unfit to drive.
Veecef CV 200mg/125mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Veecef CV 200mg/125mg Tablet may be needed. Please consult your doctor.
Veecef CV 200mg/125mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Veecef CV 200mg/125mg Tablet may be needed. Please consult your doctor.
If you miss a dose of Veecef CV 200mg/125mg Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Wellmark Lifesciences Private Limited || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Godase Healthcare || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Biovzn Pharmaceuticals || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Arlak Biotech Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Milard Life Sciences || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Lewis Bioserch Pharma Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Vintas Pharmaceuticals Pvt. Ltd. || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Disan Pharma || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Dorphyll Healthcare || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Biopolis Life Sciences Pvt Ltd || ₹14.5/tablet (25% cheaper)